EIV Capital Elevates Jason Tracton to Partner in Healthcare Push

Healthcare-focused private equity firm EIV Capital has promoted Jason Tracton to Partner, a move that underscores the Miami-based firm's commitment to deepening its bench of operational expertise as it pursues mid-market healthcare services deals. Tracton, who joined EIV in 2022 as a Principal, will now play an expanded role in sourcing, executing, and managing portfolio company value creation across the firm's healthcare vertical.

The promotion comes as healthcare services private equity continues to consolidate fragmented markets — dental practices, behavioral health clinics, veterinary hospitals — with firms racing to build platforms that can achieve scale economies while navigating regulatory complexity. EIV Capital, which manages approximately $1.5 billion in assets, has carved out a niche targeting businesses where operational transformation can unlock value beyond multiple arbitrage.

Tracton's elevation reflects a broader industry trend: firms are promoting operators, not just dealmakers. His background includes investment banking experience at Cowen and operational roles that give him credibility with management teams navigating post-acquisition integration. That skill set matters more now than it did five years ago, when simply rolling up practices could generate returns.

"Jason has been instrumental in driving value across our healthcare portfolio," said Michael Falk, Managing Partner at EIV Capital, in the announcement. "His promotion to Partner recognizes both his contributions to date and the leadership role we expect him to play as we continue building best-in-class healthcare services businesses."

Tracton arrived at EIV after spending time in Cowen's healthcare investment banking group, where he advised on M&A transactions and capital raises for middle-market healthcare companies. That banking pedigree is standard for PE associates — the unusual part is what he did with it.

At EIV, Tracton didn't just model deals. He embedded himself in portfolio companies, working alongside management on pricing strategy, payer contract negotiations, and regional expansion plans. In one case, according to people familiar with his work, he helped a home health platform redesign its reimbursement approach to capture higher-acuity patients — a change that improved margins by 300 basis points within 18 months.

That's the kind of operational fluency that gets you promoted in 2026. Private equity has spent the last decade realizing that financial engineering has limits when interest rates aren't zero and exit multiples aren't expanding. The firms winning today are the ones that can actually make their companies better at what they do.

Tracton's skill set aligns with EIV's investment thesis: target fragmented healthcare services sectors, build platforms through M&A, then drive organic growth by improving operational efficiency and service delivery. It's a thesis that works — when execution follows strategy.

The healthcare services market remains one of the most active verticals in middle-market private equity, with deal volume holding steady even as overall PE activity has cooled. Behavioral health, dental, dermatology, and home health have all seen sustained platform-building activity, driven by favorable demographics, regulatory tailwinds, and fragmentation that begs for consolidation.

But the easy money has been made. First-generation roll-ups in dental and veterinary services achieved outsized returns by simply aggregating practices and selling to strategics or larger PE buyers. Today's investors face higher entry multiples, tighter labor markets, and regulatory scrutiny that makes integration more complex.

What separates winners from losers now is operational capability. Can you retain physicians post-acquisition? Can you renegotiate payer contracts at scale? Can you implement technology that actually improves clinical workflows rather than just cutting costs? These aren't finance questions — they're operational ones.

Source: PitchBook, 2025 Healthcare Services PE Activity Report

A decade ago, you could buy independent practices at 5-6x EBITDA, roll them into a platform, and flip the platform at 12x based purely on scale. That arbitrage has compressed. Today's sellers know what PE buyers are willing to pay, and they're demanding a bigger share of the upside — either through higher purchase prices or retained equity in the platform.

EIV Capital's approach differs from larger healthcare-focused funds like Welsh, Carson, Anderson & Stowe or Summit Partners in one critical way: it stays smaller. With $1.5 billion in assets under management, EIV targets companies with $10-50 million in revenue — businesses that are large enough to have established operations but small enough that a skilled investor can still move the needle on performance.

The firm's portfolio includes companies in home health, ambulatory surgery centers, and specialty physician services. In each case, EIV's thesis centers on operational transformation: improving payer mix, expanding service lines, or entering adjacent geographies through disciplined M&A.

What makes that thesis work isn't the strategy — every mid-market healthcare PE firm claims to do the same thing. It's the people executing it. Tracton's promotion signals that EIV is investing in the kind of talent that can actually deliver on those promises.

That's not a trivial point. Portfolio company CEOs can tell the difference between a PE partner who understands their business and one who's just reading consultant decks. The best PE firms build trust with management teams by demonstrating operational fluency — knowing how reimbursement works, understanding labor economics, recognizing when to push for growth and when to consolidate.

Tracton's background suggests he can operate in that mode. His banking experience gives him the technical skills to structure deals, but his time embedded in portfolio companies gives him credibility with operators. That combination is increasingly valuable as healthcare services investing shifts from financial engineering to operational execution.

Partner promotions are signals. They tell the market what a firm values and where it's headed. By elevating Tracton, EIV is signaling that healthcare services remains a core focus — and that it's willing to invest in senior talent to execute on that strategy.

It also suggests EIV is preparing for a larger fund. Firms typically promote Partners in advance of fundraising cycles, both to demonstrate bench depth to LPs and to ensure they have the team in place to deploy capital at scale. If EIV raises a Fund IV in the next 18 months — as industry observers expect — Tracton's promotion positions him to lead deal teams and manage a larger portfolio of healthcare investments.

Tracton's promotion reflects a broader shift in how private equity firms build leadership pipelines. Twenty years ago, the path to Partner was straightforward: close deals, generate returns, get promoted. Today, it's more nuanced.

Firms are promoting people who can do more than source and execute transactions. They want Partners who can sit on boards and guide strategy. Who can recruit and retain management talent. Who can navigate regulatory complexity and manage LP relationships. Who can build value, not just buy it.

That evolution is healthy for the industry. The PE firms that win over the next decade will be the ones that recognize value creation is a team sport — and that the best teams promote players who make everyone around them better.

For Tracton, the challenge now is proving that the operational wins he's delivered as a Principal can scale as he takes on broader responsibilities. That means sourcing new deals, managing larger portfolio companies, and mentoring junior investors — all while maintaining the hands-on operational engagement that got him promoted in the first place.

The skill set required to succeed as a PE Partner has expanded. You still need to be a strong investor — capable of underwriting risk, structuring deals, and generating returns. But you also need to be a leader, an operator, and increasingly, a sector expert.

In healthcare services, that means understanding clinical workflows, payer economics, and regulatory frameworks. It means knowing when to push for aggressive growth and when to prioritize margin improvement. It means building relationships with management teams that survive the inevitable bumps in any value creation plan.

EIV Capital operates in a crowded field. The mid-market healthcare services space is home to dozens of active investors, ranging from dedicated healthcare funds like Frazier Healthcare Partners and Arsenal Capital Partners to generalist middle-market firms like Gryphon Investors and NovaQuest Capital.

What differentiates EIV is its willingness to go smaller than many of its peers. While larger funds chase $100 million+ EBITDA platforms, EIV focuses on earlier-stage businesses where operational improvement can drive disproportionate value creation. That strategy requires more hands-on work — which is why having Partners like Tracton who can lead that effort matters.

Source: Firm websites, PitchBook data, industry estimates

The competitive intensity in healthcare services PE means firms need to move fast and add value quickly. LPs are tired of hearing about "operational value creation" as a buzzword — they want to see evidence of it in portfolio performance. Tracton's track record suggests he can deliver that evidence, which is why his promotion carries weight beyond the press release.

Tracton's promotion sets up a few questions worth tracking over the next 12-18 months. First, does EIV announce a new fund? If so, what's the target size — and does it signal a move upmarket or a continuation of the firm's current strategy?

Second, where does EIV deploy capital next? The firm has been active in home health and specialty physician services — are there adjacent verticals where Tracton's operational expertise could unlock similar value? Behavioral health and post-acute care remain underpenetrated relative to dental and veterinary services.

Third, does EIV make more senior hires or promote from within? Partner promotions often precede team expansion, either through lateral hires or by accelerating the development of junior investors. If EIV is serious about scaling its healthcare platform, it'll need more than one newly minted Partner to execute.

Those answers will reveal whether this promotion is a milestone in EIV's evolution — or just another press release in a crowded market.

Step back from the individual promotion and the broader trend is clear: healthcare services private equity remains one of the most durable themes in middle-market investing. Demographic tailwinds, regulatory complexity, and persistent fragmentation create conditions that favor sophisticated buyers who can build platforms and improve operations.

But the bar for success is higher than it was five years ago. Entry multiples have risen. Sellers are more sophisticated. Labor markets are tighter. And LPs are demanding proof of operational value creation, not just multiple expansion.

The firms that win in this environment will be the ones that invest in people who can deliver on operational promises. Tracton's promotion suggests EIV understands that — and is willing to bet on talent that can execute, not just pitch.

Whether that bet pays off depends on what comes next. Partner titles are easy to hand out. Value creation is harder.